An internationally recognised centre of health excellence
The Côte d’Azur is the 2nd region in France for clinical trials and 2nd for Life Sciences.
The Côte d’Azur Health & Life Sciences sector
Innovation in life sciences and technologies is supported on the Côte d’Azur by public research structured around the Institute of Molecular and Cellular Pharmacology (IPMC), the Mediterranean Centre for Molecular Medicine (C3M), the Valrose Institute of Biology (IBV), the Institute of Research on Cancer and Ageing (IRCAN), the Antoine Lacassagne Centre, the Nice Institute of Chemistry and the National Institute of Research in Computer Science and Automation (INRIA)
Figures for the Health & Life Sciences sector
- 432 establishments, including 102 in the Nice Côte d’Azur metropolitan area
- 2.6 billion euros in turnover, more than half of which is exported (€675 million in the Nice Côte d’Azur metropolitan area)
- 9,900 salaried jobs, including 3,016 in the Nice Côte d’Azur metropolitan area
- 6 fields of activity: aromatic industry, pharmaceutical industry (more particularly in the Carros business park), basic chemistry, biomedical engineering, cosmetology, plant world.
- The Life Sciences sector also stands out for its high proportion of start-ups (23 between 2018 and 2021). The volume of fundraising reached 97.5 million euros.
- Weight of the health industry in the Life Sciences sector: 54% of establishments, 53% of jobs and 52% of turnover.
Sources: Sirius-CCI Nice Côte d’Azur Economic Observatory
Nice University Hospital
The University Hospital of Nice is a public health establishment with a triple mission: care, teaching and research.
A multi-site hospital (different hospital sites in Nice and Tende, specialised and complementary: Pasteur, L’Archet, Cimiez, Saint-Roch, Tende, Institut Universitaire de la Face et du Cou, Institut Claude Pompidou), the CHU employs more than 7,500 professionals with a wide range of skills to ensure quality care.
The Nice University Hospital is made up of 5 hospitals (L’Archet, Saint Roch, Pasteur, Cimiez and Tende) plus 3 establishments within which cooperation has been established (Pompidou Centre – a pilot centre for care, research and prevention of Alzheimer’s disease -, the Face and Neck Institute – a reference centre for oncology and cervico-facial surgery – and Lenval Paediatric Hospital).
The CHU is also 139 hospital services, 940 scientific publications in 2020, 1,384 research projects in progress, 1,200 medical students, 600 students in paramedical training, 9,000 professionals, 440,000 days of hospitalization per year.
The Antoine Lacassagne Centre
THE ANTOINE LACASSAGNE CENTRE HAS BEEN RANKED AMONG THE TOP 100 CANCER HOSPITALS IN THE WORLD IN 2021 BY THE AMERICAN MAGAZINE NEWSWEEK. It has one of the most sophisticated machines in the world for the treatment of cancer.
For more than 50 years, the Antoine Lacassagne Centre has been offering the population of the PACA-Est region a very high level technical platform, particularly in radiotherapy with the Cyclotron and the CyberKnife®. The Centre is also a partner of the CNRS, with research teams based on its premises. It is a leading centre for medical oncology and breast and ENT cancer surgery. Together with the Nice University Hospital, it forms the regional cancer centre.
Health and 3IA
As part of the national programme for artificial intelligence (AI), the State has decided to support the constitution of a network composed of a small number of Interdisciplinary Institutes of Artificial Intelligence (3IA) with which the whole of the French potential in AI will have a vocation to interact.
The 3IA Côte d’Azur project (Interdisciplinary Institute of Artificial Intelligence) was validated on 24 April 2019 by the Ministry of Higher Education, Research and Innovation. The Alpes-Maritimes thus becomes part of the very small network of artificial intelligence in France, alongside the three other 3IA institutes in Paris, Grenoble and Toulouse.
Health is one of the fundamental research areas of the 3IA Institute, with digital medicine and AI for digital biology. These areas are therefore linked to digital health and also involve health data management. The digital twin, with its digital representation of the patient’s anatomy and physiology, is becoming the core of the theme.
The competitiveness cluster is the merger of Eurobiomed and Cancer-Bio-Santé, dedicated to innovation in the medical field, on the Mediterranean territory from Toulouse to Nice. The services offered are support, acceleration, European projects, regulatory aspects and international activities for companies and start-ups in the health, biotechnology and medical device sectors.
Eurobiomed supports the transformation of innovations into health products and services for the patient and accelerates the development of the cluster’s companies and territories. The cluster’s ambition is to become the European leader in the growth of health SMEs and the development of innovation (1st HealthTech SME cluster in Europe).
The Silver Economy
Ageing well while remaining at home is one of the concerns of the public authorities of the Nice Côte d’Azur metropolitan area.
- 560 establishments in the Alpes-Maritimes
- 10,640 salaried jobs
- 1⁄4 of jobs located in Nice
- 50% of establishments positioned in the “Homecare” sector
- 1,000 jobs linked to E-health
- One third of Silver Economy establishments are positioned in a personal services offer.
- The Nice basin concentrates nearly 200 establishments, with a slight specialisation in the “ageing well” sector.
Sources: Sirius-CCI Nice Côte d’Azur Economic Observatory – 2020